Alnylam Pharmaceuticals Aktie
244,40
EUR
-0,80
EUR
-0,33
%
286,28
USD
-0,57
USD
-0,20
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung